Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2025-12-25 @ 1:25 AM
NCT ID:
NCT00341393
Eligibility Criteria:
* INCLUSION CRITERIA:
1. Willing to provide individual informed consent.
2. HIV positive. (HIV status will have been confirmed by recognised external testing centre (eg AIC) or if necessary by the IDI lab using Abbott Determine HIV1-2 plus STAT-PAK (Chembio Diagnostic Systems) rapid tests. Unigold (Trinity Biotech) is available for 'tie-breaker' testing if necessary.
3. Currently being followed at the Adult Infectious Disease Clinic.
4. Patients who are aged 18 years or more.
5. Patients on ART for more than 6 months who are PI naive.
EXCLUSION CRITERIA:
1. Inability or unwillingness to provide individual informed consent.
2. Patients currently admitted to 'Urgent Care' facility.
3. Age less than 18 years.
4. Patients enrolled in either 'Clinic' or 'Gates 5B' cohorts.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00341393
Study Brief:
Protocol Section:
NCT00341393